SEB Asset Management AB »

Ionis Pharmaceuticals shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Ionis Pharmaceuticals (IONS) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.6M 114k 75.09

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding Ionis Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
T. Rowe Price Investment Management
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
Two Sigma Investments
Bellevue Group
Geode Capital Management
State Street Corporation
Royal Bank of Canada
Tweedy, Browne Company
Artisan Partners Limited Partnership

View all funds holding Ionis Pharmaceuticals